These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 17266927

  • 21. Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression.
    Carreira S, Goodall J, Aksan I, La Rocca SA, Galibert MD, Denat L, Larue L, Goding CR.
    Nature; 2005 Feb 17; 433(7027):764-9. PubMed ID: 15716956
    [Abstract] [Full Text] [Related]

  • 22. Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
    Dynek JN, Chan SM, Liu J, Zha J, Fairbrother WJ, Vucic D.
    Cancer Res; 2008 May 01; 68(9):3124-32. PubMed ID: 18451137
    [Abstract] [Full Text] [Related]

  • 23. SOX5 is involved in balanced MITF regulation in human melanoma cells.
    Kordaß T, Weber CE, Oswald M, Ast V, Bernhardt M, Novak D, Utikal J, Eichmüller SB, König R.
    BMC Med Genomics; 2016 Feb 29; 9():10. PubMed ID: 26927636
    [Abstract] [Full Text] [Related]

  • 24. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
    Samija I, Lukac J, Marić-Brozić J, Buljan M, Alajbeg I, Kovacević D, Situm M, Kusić Z.
    Melanoma Res; 2010 Aug 29; 20(4):293-302. PubMed ID: 20357686
    [Abstract] [Full Text] [Related]

  • 25. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
    Strub T, Giuliano S, Ye T, Bonet C, Keime C, Kobi D, Le Gras S, Cormont M, Ballotti R, Bertolotto C, Davidson I.
    Oncogene; 2011 May 19; 30(20):2319-32. PubMed ID: 21258399
    [Abstract] [Full Text] [Related]

  • 26. Microphthalmia-associated transcription factor gene amplification in metastatic melanoma is a prognostic marker for patient survival, but not a predictive marker for chemosensitivity and chemotherapy response.
    Ugurel S, Houben R, Schrama D, Voigt H, Zapatka M, Schadendorf D, Bröcker EB, Becker JC.
    Clin Cancer Res; 2007 Nov 01; 13(21):6344-50. PubMed ID: 17975146
    [Abstract] [Full Text] [Related]

  • 27. Mechanism of Mitf inhibition and morphological differentiation effects of hirsein A on B16 melanoma cells revealed by DNA microarray.
    Villareal MO, Han J, Ikuta K, Isoda H.
    J Dermatol Sci; 2012 Jul 01; 67(1):26-36. PubMed ID: 22564683
    [Abstract] [Full Text] [Related]

  • 28. ERK-regulated differential expression of the Mitf 6a/b splicing isoforms in melanoma.
    Primot A, Mogha A, Corre S, Roberts K, Debbache J, Adamski H, Dreno B, Khammari A, Lesimple T, Mereau A, Goding CR, Galibert MD.
    Pigment Cell Melanoma Res; 2010 Feb 01; 23(1):93-102. PubMed ID: 19895547
    [Abstract] [Full Text] [Related]

  • 29. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
    Wellbrock C, Marais R.
    J Cell Biol; 2005 Aug 29; 170(5):703-8. PubMed ID: 16129781
    [Abstract] [Full Text] [Related]

  • 30. miR-211 and MITF modulation by Bcl-2 protein in melanoma cells.
    De Luca T, Pelosi A, Trisciuoglio D, D'Aguanno S, Desideri M, Farini V, Di Martile M, Bellei B, Tupone MG, Candiloro A, Regazzo G, Rizzo MG, Del Bufalo D.
    Mol Carcinog; 2016 Dec 29; 55(12):2304-2312. PubMed ID: 26599548
    [Abstract] [Full Text] [Related]

  • 31. PD-L1 expression is regulated by microphthalmia-associated transcription factor (MITF) in nodular melanoma.
    Vučinić D, Grahovac M, Grahovac B, Vitezić BM, Kovač L, Belušić-Gobić M, Zamolo G.
    Pathol Res Pract; 2022 Jan 29; 229():153725. PubMed ID: 34942512
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.
    Swoboda A, Soukup R, Eckel O, Kinslechner K, Wingelhofer B, Schörghofer D, Sternberg C, Pham HTT, Vallianou M, Horvath J, Stoiber D, Kenner L, Larue L, Poli V, Beermann F, Yokota T, Kubicek S, Krausgruber T, Rendeiro AF, Bock C, Zenz R, Kovacic B, Aberger F, Hengstschläger M, Petzelbauer P, Mikula M, Moriggl R.
    Oncogene; 2021 Feb 29; 40(6):1091-1105. PubMed ID: 33323974
    [Abstract] [Full Text] [Related]

  • 34. Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.
    Chen X, Wang J, Shen H, Lu J, Li C, Hu DN, Dong XD, Yan D, Tu L.
    Invest Ophthalmol Vis Sci; 2011 Mar 02; 52(3):1193-9. PubMed ID: 21051724
    [Abstract] [Full Text] [Related]

  • 35. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
    Noguchi K, Dalton AC, Howley BV, McCall BJ, Yoshida A, Diehl JA, Howe PH.
    PLoS One; 2017 Mar 02; 12(5):e0177830. PubMed ID: 28545079
    [Abstract] [Full Text] [Related]

  • 36. Sphingolipid-mediated restoration of Mitf expression and repigmentation in vivo in a mouse model of hair graying.
    Saha B, Singh SK, Mallick S, Bera R, Datta PK, Mandal M, Roy S, Bhadra R.
    Pigment Cell Melanoma Res; 2009 Apr 02; 22(2):205-18. PubMed ID: 19207217
    [Abstract] [Full Text] [Related]

  • 37. Commentary. A picture of Mitf in melanoma immortality.
    Goding CR.
    Oncogene; 2011 May 19; 30(20):2304-6. PubMed ID: 21278792
    [Abstract] [Full Text] [Related]

  • 38. Lipocalin-type prostaglandin D synthase as a melanocyte marker regulated by MITF.
    Takeda K, Yokoyama S, Aburatani H, Masuda T, Han F, Yoshizawa M, Yamaki N, Yamamoto H, Eguchi N, Urade Y, Shibahara S.
    Biochem Biophys Res Commun; 2006 Jan 27; 339(4):1098-106. PubMed ID: 16337607
    [Abstract] [Full Text] [Related]

  • 39. MITF, the Janus transcription factor of melanoma.
    Koludrovic D, Davidson I.
    Future Oncol; 2013 Feb 27; 9(2):235-44. PubMed ID: 23414473
    [Abstract] [Full Text] [Related]

  • 40. PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.
    Grabacka M, Placha W, Urbanska K, Laidler P, Płonka PM, Reiss K.
    Pigment Cell Melanoma Res; 2008 Jun 27; 21(3):388-96. PubMed ID: 18444964
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.